Our study revealed that seven kinases, CTNNB1, CRK, EGFR, ERBB2, PIK3R1, PLCG1, and PTPN11, were highly activated in all NSCLC patients harboring sensitizing EGFR mutations. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.